Zimulti Unia Europejska - słoweński - EMA (European Medicines Agency)

zimulti

sanofi-aventis - rimonabant - debelost - preparati za zaščito proti sončenju, prehrambeni izdelki - kot dodatek k prehrani in vadbi za zdravljenje debelih bolnikih (itm 30 kg/m2), ali bolnikov s prekomerno telesno težo (itm 27 kg/m2) s pripadajočimi dejavnik tveganja(i), kot so diabetes tipa 2 ali dyslipidaemia (glej poglavje 5.

UBROLEXIN Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ubrolexin

cefaleksin (v obliki cefaleksinijevega monohidrata): 200 mg kanamicin (v obliki kanamicinijevega sulfata): 100 -

Delstrigo Unia Europejska - słoweński - EMA (European Medicines Agency)

delstrigo

merck sharp & dohme b.v. - doravirine, lamivudine, tenofovir disoproxil fumarate - okužbe z virusom hiv - antivirusi za zdravljenje okužb z virusom hiv, kombinacije - delstrigo je indiciran za zdravljenje odraslih, okuženih z virusom hiv 1 brez preteklosti ali sedanjosti dokazov odpornost proti nnrti razred, lamivudine, ali tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Pifeltro Unia Europejska - słoweński - EMA (European Medicines Agency)

pifeltro

merck sharp & dohme b.v. - doravirine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Ervebo Unia Europejska - słoweński - EMA (European Medicines Agency)

ervebo

merck sharp & dohme b.v.  - rekombinantne vezikularni stomatitis virus (sev, indiana) z izbrisom sredstev glikoprotein, nadomesti z zaire ebolavirus (sev kikwit 1995) površine glikoprotein - hemoragične mrzlice, ebola - cepiva - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. uporaba ervebo mora biti v skladu z uradnimi priporočili.